FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293589635> ?p ?o ?g. }

• W4293589635 abstract "This article is based on recommendations from the 12th WALT Congress, Nice, October 3-6, 2018, and a follow-up review of the existing data and the clinical observations of an international multidisciplinary panel of clinicians and researchers with expertise in the area of supportive care in cancer and/or PBM clinical application and dosimetry. This article is informational in nature. As with all clinical materials, this paper should be used with a clear understanding that continued research and practice could result in new insights and recommendations. The review reflects the collective opinion and, as such, does not necessarily represent the opinion of any individual author. In no event shall the authors be liable for any decision made or action taken in reliance on the proposed protocols.This position paper reviews the potential prophylactic and therapeutic effects of photobiomodulation (PBM) on side effects of cancer therapy, including chemotherapy (CT), radiation therapy (RT), and hematopoietic stem cell transplantation (HSCT).There is a considerable body of evidence supporting the efficacy of PBM for preventing oral mucositis (OM) in patients undergoing RT for head and neck cancer (HNC), CT, or HSCT. This could enhance patients' quality of life, adherence to the prescribed cancer therapy, and treatment outcomes while reducing the cost of cancer care.A literature review on PBM effectiveness and dosimetry considerations for managing certain complications of cancer therapy were conducted. A systematic review was conducted when numerous randomized controlled trials were available. Results were presented and discussed at an international consensus meeting at the World Association of photobiomoduLation Therapy (WALT) meeting in 2018 that included world expert oncologists, radiation oncologists, oral oncologists, and oral medicine professionals, physicists, engineers, and oncology researchers. The potential mechanism of action of PBM and evidence of PBM efficacy through reported outcomes for individual indications were assessed.There is a large body of evidence demonstrating the efficacy of PBM for preventing OM in certain cancer patient populations, as recently outlined by the Multinational Association for Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Building on these, the WALT group outlines evidence and prescribed PBM treatment parameters for prophylactic and therapeutic use in supportive care for radiodermatitis, dysphagia, xerostomia, dysgeusia, trismus, mucosal and bone necrosis, lymphedema, hand-foot syndrome, alopecia, oral and dermatologic chronic graft-versus-host disease, voice/speech alterations, peripheral neuropathy, and late fibrosis amongst cancer survivors.There is robust evidence for using PBM to prevent and treat a broad range of complications in cancer care. Specific clinical practice guidelines or evidence-based expert consensus recommendations are provided. These recommendations are aimed at improving the clinical utilization of PBM therapy in supportive cancer care and promoting research in this field. It is anticipated these guidelines will be revised periodically." @default.
• W4293589635 created "2022-08-30" @default.
• W4293589635 creator A5001374433 @default.
• W4293589635 creator A5001715618 @default.
• W4293589635 creator A5005296350 @default.
• W4293589635 creator A5005549850 @default.
• W4293589635 creator A5006856522 @default.
• W4293589635 creator A5016481189 @default.
• W4293589635 creator A5018624121 @default.
• W4293589635 creator A5018909095 @default.
• W4293589635 creator A5019712105 @default.
• W4293589635 creator A5022594161 @default.
• W4293589635 creator A5023136233 @default.
• W4293589635 creator A5028274750 @default.
• W4293589635 creator A5033528539 @default.
• W4293589635 creator A5038557062 @default.
• W4293589635 creator A5041858725 @default.
• W4293589635 creator A5043062547 @default.
• W4293589635 creator A5046156308 @default.
• W4293589635 creator A5048060803 @default.
• W4293589635 creator A5055005316 @default.
• W4293589635 creator A5058501386 @default.
• W4293589635 creator A5063034657 @default.
• W4293589635 creator A5067813330 @default.
• W4293589635 creator A5070553065 @default.
• W4293589635 creator A5071838552 @default.
• W4293589635 creator A5078146255 @default.
• W4293589635 creator A5081678128 @default.
• W4293589635 creator A5081808602 @default.
• W4293589635 creator A5082281519 @default.
• W4293589635 creator A5082455844 @default.
• W4293589635 creator A5090469475 @default.
• W4293589635 creator A5091262335 @default.
• W4293589635 creator A5091649762 @default.
• W4293589635 date "2022-08-30" @default.
• W4293589635 modified "2023-10-09" @default.
• W4293589635 title "Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022" @default.
• W4293589635 cites W11508073 @default.
• W4293589635 cites W1583511338 @default.
• W4293589635 cites W1645109723 @default.
• W4293589635 cites W1668023273 @default.
• W4293589635 cites W1755456902 @default.
• W4293589635 cites W1788256932 @default.
• W4293589635 cites W1846516945 @default.
• W4293589635 cites W1859496906 @default.
• W4293589635 cites W1900328804 @default.
• W4293589635 cites W1926878764 @default.
• W4293589635 cites W1928191078 @default.
• W4293589635 cites W1964531456 @default.
• W4293589635 cites W1966725702 @default.
• W4293589635 cites W1968773992 @default.
• W4293589635 cites W1970594607 @default.
• W4293589635 cites W1971612996 @default.
• W4293589635 cites W1973061338 @default.
• W4293589635 cites W1973681161 @default.
• W4293589635 cites W1973738842 @default.
• W4293589635 cites W1973845335 @default.
• W4293589635 cites W1977209653 @default.
• W4293589635 cites W1977719994 @default.
• W4293589635 cites W1978350956 @default.
• W4293589635 cites W1978490160 @default.
• W4293589635 cites W1979804303 @default.
• W4293589635 cites W1983790564 @default.
• W4293589635 cites W1988186988 @default.
• W4293589635 cites W1988544505 @default.
• W4293589635 cites W1989155114 @default.
• W4293589635 cites W1989977761 @default.
• W4293589635 cites W1992542119 @default.
• W4293589635 cites W1995647190 @default.
• W4293589635 cites W1996332259 @default.
• W4293589635 cites W1998817643 @default.
• W4293589635 cites W1999075599 @default.
• W4293589635 cites W2001904246 @default.
• W4293589635 cites W2002055844 @default.
• W4293589635 cites W2004020565 @default.
• W4293589635 cites W2004613565 @default.
• W4293589635 cites W2008605336 @default.
• W4293589635 cites W2009537560 @default.
• W4293589635 cites W2010842195 @default.
• W4293589635 cites W2013141816 @default.
• W4293589635 cites W2014162945 @default.
• W4293589635 cites W2014828795 @default.
• W4293589635 cites W2015617634 @default.
• W4293589635 cites W2015743573 @default.
• W4293589635 cites W2016858035 @default.
• W4293589635 cites W2018859387 @default.
• W4293589635 cites W2021268953 @default.
• W4293589635 cites W2021394202 @default.
• W4293589635 cites W2022020555 @default.
• W4293589635 cites W2023628234 @default.
• W4293589635 cites W2027510392 @default.
• W4293589635 cites W2032053039 @default.
• W4293589635 cites W2034827129 @default.
• W4293589635 cites W2035168317 @default.
• W4293589635 cites W2035350682 @default.
• W4293589635 cites W2037297313 @default.
• W4293589635 cites W2038213741 @default.
• W4293589635 cites W2038574724 @default.
• W4293589635 cites W2040655747 @default.
• W4293589635 cites W2040777953 @default.

• next